| 发明名称 |
FIBROBLAST GROWTH FACTOR 21 PROTEINS 21 |
| 摘要 |
<p>This present invention relates to pharmacologically potent and stable human fibroblast growth factor 21 (FGF21) proteins, pharmaceutical compositions comprising FGF21 proteins, and methods for treating type 2 diabetes, obesity, dyslipidemia, and/or metabolic syndrome using such proteins.</p> |
| 申请公布号 |
HK1203357(A1) |
申请公布日期 |
2015.10.30 |
| 申请号 |
HK20150103818 |
申请日期 |
2015.04.20 |
| 申请人 |
ELI LILLY & COMPANY LIMITED |
发明人 |
DARLING, RYAN JAMES;DICKINSON, CRAIG DUANE;DRIVER, DAVID ALBERT;GONCIARZ, MALGORZATA DONATA |
| 分类号 |
A61K;C07K |
主分类号 |
A61K |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
